Literature DB >> 31388873

The Association of Immune Markers with Cognitive Performance in South African HIV-Positive Patients.

Monray E Williams1, Jonathan C Ipser2, Dan J Stein2,3, John A Joska4, Petrus J W Naudé2.   

Abstract

Dysregulated expression of neuro-immune markers has previously been linked to HIV-associated neurocognitive impairment. We undertook an exploratory approach in a HIV clade-C cohort, investigating the association between eight immune markers and neurocognitive performance in 99 HIV+ and 51 HIV- participants. Markers were selected on preliminary and putative evidence of their link to key neuro-immune functions. Cognitive performance was established using a battery of tests sensitive to HIV-associated neurocognitive impairment, with domain-based scores utilized in analysis. The markers Thymidine phosphorylase (TYMP) and Neutrophil gelatinase-associated lipocalin (NGAL) were significantly higher while Matrix Metalloproteinase (MMP)9 was significantly lower in HIV+ participants. Our results further showed that in the HIV+ group, worse psychomotor processing speed was associated with higher TYMP and NGAL levels and worse motor function was associated with higher NGAL levels. Future studies should explore the underlying mechanisms of these markers in HIV-associated neurocognitive impairment. Graphical Abstract The association of peripheral immune markers with neurocognitive performance in South African HIV-positive patients.

Entities:  

Keywords:  Cognition; HAND; HIV; HIV-associated neurocognitive impairments; Neuroinflammation and cytokines

Mesh:

Substances:

Year:  2019        PMID: 31388873     DOI: 10.1007/s11481-019-09870-1

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  56 in total

1.  Category fluency test: normative data for English- and Spanish-speaking elderly.

Authors:  A Acevedo; D A Loewenstein; W W Barker; D G Harwood; C Luis; M Bravo; D A Hurwitz; H Aguero; L Greenfield; R Duara
Journal:  J Int Neuropsychol Soc       Date:  2000-11       Impact factor: 2.892

2.  A group version of the Stroop Color and Word Test.

Authors:  C J Golden
Journal:  J Pers Assess       Date:  1975-08

3.  HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study.

Authors:  R K Heaton; D B Clifford; D R Franklin; S P Woods; C Ake; F Vaida; R J Ellis; S L Letendre; T D Marcotte; J H Atkinson; M Rivera-Mindt; O R Vigil; M J Taylor; A C Collier; C M Marra; B B Gelman; J C McArthur; S Morgello; D M Simpson; J A McCutchan; I Abramson; A Gamst; C Fennema-Notestine; T L Jernigan; J Wong; I Grant
Journal:  Neurology       Date:  2010-12-07       Impact factor: 9.910

4.  Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients.

Authors:  B Sporer; R Paul; U Koedel; R Grimm; M Wick; F D Goebel; H W Pfister
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

5.  Secreted protein lipocalin-2 promotes microglial M1 polarization.

Authors:  Eunha Jang; Shinrye Lee; Jong-Heon Kim; Jae-Hong Kim; Jung-Wan Seo; Won-Ha Lee; Kiyoshi Mori; Kazuwa Nakao; Kyoungho Suk
Journal:  FASEB J       Date:  2012-12-03       Impact factor: 5.191

Review 6.  Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches.

Authors:  N Butters; I Grant; J Haxby; L L Judd; A Martin; J McClelland; W Pequegnat; D Schacter; E Stover
Journal:  J Clin Exp Neuropsychol       Date:  1990-12       Impact factor: 2.475

7.  Sex differences in soluble markers vary before and after the initiation of antiretroviral therapy in chronically HIV-infected individuals.

Authors:  Shelly J Krebs; Bonnie M Slike; Pasiri Sithinamsuwan; Isabel E Allen; Thep Chalermchai; Somporn Tipsuk; Nittaya Phanuphak; Linda Jagodzinski; Jerome H Kim; Jintanat Ananworanich; Mary A Marovich; Victor G Valcour
Journal:  AIDS       Date:  2016-06-19       Impact factor: 4.177

8.  The relationship of CSF and plasma cytokine levels in HIV infected patients with neurocognitive impairment.

Authors:  Lin Yuan; An Liu; Luxin Qiao; Bo Sheng; Meng Xu; Wei Li; Dexi Chen
Journal:  Biomed Res Int       Date:  2015-03-03       Impact factor: 3.411

9.  Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence.

Authors:  Vasudev R Rao; Ujjwal Neogi; Joshua S Talboom; Ligia Padilla; Mustafizur Rahman; Cari Fritz-French; Sandra Gonzalez-Ramirez; Anjali Verma; Charles Wood; Ruth M Ruprecht; Udaykumar Ranga; Tasnim Azim; John Joska; Eliseo Eugenin; Anita Shet; Heather Bimonte-Nelson; William R Tyor; Vinayaka R Prasad
Journal:  Retrovirology       Date:  2013-06-08       Impact factor: 4.602

Review 10.  Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders.

Authors:  Han Liu; Enquan Xu; Jianuo Liu; Huangui Xiong
Journal:  Brain Sci       Date:  2016-07-22
View more
  5 in total

Review 1.  Transcriptomic and Genetic Profiling of HIV-Associated Neurocognitive Disorders.

Authors:  Daniel Ojeda-Juárez; Marcus Kaul
Journal:  Front Mol Biosci       Date:  2021-10-29

2.  Molecular Modeling of Subtype-Specific Tat Protein Signatures to Predict Tat-TAR Interactions That May Be Involved in HIV-Associated Neurocognitive Disorders.

Authors:  Monray E Williams; Ruben Cloete
Journal:  Front Microbiol       Date:  2022-04-07       Impact factor: 5.640

3.  Association of maternal and infant inflammation with neurodevelopment in HIV-exposed uninfected children in a South African birth cohort.

Authors:  Tatum Sevenoaks; Catherine J Wedderburn; Kirsten A Donald; Whitney Barnett; Heather J Zar; Dan J Stein; Petrus J W Naudé
Journal:  Brain Behav Immun       Date:  2020-08-26       Impact factor: 7.217

Review 4.  HIV and Proteomics: What We Have Learned from High Throughput Studies.

Authors:  Kinga Grabowska; Emma Harwood; Pawel Ciborowski
Journal:  Proteomics Clin Appl       Date:  2020-10-14       Impact factor: 3.494

5.  Lipocalin-2 mediates HIV-1 induced neuronal injury and behavioral deficits by overriding CCR5-dependent protection.

Authors:  Daniel Ojeda-Juárez; Rohan Shah; Jerel Adam Fields; Indira S Harahap-Carrillo; Jeffrey Koury; Ricky Maung; Benjamin B Gelman; Bas J Baaten; Amanda J Roberts; Marcus Kaul
Journal:  Brain Behav Immun       Date:  2020-06-11       Impact factor: 7.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.